Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Cardinal Health
CAH
Market cap
$37B
Overview
Fund Trends
Analyst Outlook
Journalist POV
155.67
USD
+1.48
0.96%
At close
Updated
Oct 15, 4:00 PM EDT
Pre-market
After hours
155.67
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
0.96%
5 days
-1.33%
1 month
3.59%
3 months
-3.32%
6 months
15.96%
Year to date
31.9%
1 year
39.02%
5 years
218.21%
10 years
96.7%
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
30.2%
Negative
Positive
Neutral
Negative
Negative
Zacks Investment Research
2 days ago
Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade
The latest trading day saw Cardinal Health (CAH) settling at $154.31, representing a -1.64% change from its previous close.
Positive
Zacks Investment Research
2 days ago
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Neutral
Zacks Investment Research
7 days ago
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.
Positive
Zacks Investment Research
8 days ago
CAH Expands Distribution Network With Indianapolis Facility
Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.
Positive
Zacks Investment Research
9 days ago
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
Zacks Investment Research
12 days ago
Cardinal Health (CAH) Stock Dips While Market Gains: Key Facts
The latest trading day saw Cardinal Health (CAH) settling at $154.46, representing a -2.52% change from its previous close.
Positive
Zacks Investment Research
12 days ago
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
WSJ
15 days ago
Cardinal Health to Build Indianapolis Pharma Plant to Supply Growing Distribution
The planned 230,000 square-foot plant is the healthcare company's latest step in a 10-year plan to modernize and expand its distribution network.
Neutral
PRNewsWire
15 days ago
Cardinal Health to expand pharmaceutical distribution network with new Indianapolis facility
DUBLIN, Ohio , Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and modernize its national pharmaceutical distribution network.
Positive
Seeking Alpha
17 days ago
Best Dividend Aristocrats For October 2025
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristocrats already raising payouts in 2025 at an average rate of 5.19%, nearing last year's pace. 22 Dividend Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close